AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Boys With DMD

Description

This is an observational screening study to evaluate the prevalence of anti-adeno-associated serotype 8 (AAV8) antibodies in participants with Duchenne muscular dystrophy (DMD).

Conditions

Duchenne Muscular Dystrophy

Talk to us

Study Overview

On this page

Study Details

Study overview

This is an observational screening study to evaluate the prevalence of anti-adeno-associated serotype 8 (AAV8) antibodies in participants with Duchenne muscular dystrophy (DMD).

Anti-AAV8 Antibody Assessment Study of Boys With Duchenne Muscular Dystrophy Aged 0 to <12 Years

AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Boys With DMD

Condition
Duchenne Muscular Dystrophy
Intervention / Treatment

-

Contacts and Locations

Atlanta

Rare Disease Research, Atlanta, Georgia, United States, 30329

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Males at least 0 to \<12 years of age
  • * Diagnosis of DMD
  • * Provision of signed and dated informed consent form (ICF) and assent as required per local regulations or requirements
  • * Prior participation in a gene therapy trial OR recipient of a gene therapy drug
  • * Other inclusion/exclusion criteria apply

Ages Eligible for Study

0 Years to 11 Years

Sexes Eligible for Study

MALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

REGENXBIO Inc.,

Study Record Dates

2024-12